High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Chromatography A

• Publication date

  1993-12-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0378-4347(93)80252-YPMID 8120116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples.

  1993cited by this paper
• Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1.

  1991cited by this paper
• Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects.

  1991cited by this paper
• Estimation of the analgesic muscle relaxants chlorzoxazone and diazepam in human plasma by reversed-phase liquid chromatography.

  1990cited by this paper
• Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1

  1990cited by this paper
• Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples.

  1990cited by this paper
• Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake

  1989cited by this paper
• High-performance liquid chromatography with electrochemical detection of chlorzoxazone and its hydroxy metabolite in serum using solid-phase extraction.

  1986cited by this paper
• Pharmacokinetics of chlorzoxazone in humans.

  1983cited by this paper
• Fluorometric determination of chlorzoxazone in tablets and biological fluids.

  1979cited by this paper
• Liquid chromatography in pharmaceutical analysis X: Determination of chlorzoxazone and hydroxy metabolite in plasma.

  1979cited by this paper
• Physiological disposition and metabolic fate of chlorzoxazone (paraflex) in man.

  1960cited by this paper

• Feasible salting-out assisted extraction integrated with green TLC approach for concurrent chlorzoxazone and ibuprofen determination in human plasma.

  2025cites this paper
• Effect of Clomethiazole Vs. Clorazepate on Hepatic Fat and Serum Transaminase Activities in Alcohol-Associated Liver Disease: Results from a Randomized, Controlled Phase II Clinical Trial.

  2022cites this paper
• Amalgamation of in-silico, in-vitro and in-vivo approach to establish glabridin as a potential CYP2E1 inhibitor

  2021cites this paper
• Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes

  2018cites this paper
• Evaluation of cytochrome P4502E1 polymorphisms in healthy adult Western Indians and patients with antituberculous drug-induced hepatotoxicity

  2016cites this paper
• Micellar Liquid Chromatography and Derivative Spectrophotometry for the Simultaneous Determination of Acemetacin and Chlorzoxazone in their Tablets and Human Plasma

  2015cites this paper
• Évaluation de la génotoxicité des contaminants environnementaux, production de lignées bio-senseurs et mesure de l'activité enzymatique du cytochrome P450 2E1 dans les cellules d'hépatome humain HepaRG

  2015cites this paper
• Development and Validation of RP-HPLC Method for the Estimation of Chlorzoxazone in bulk drug and pharmaceutical Formulations

  2014cites this paper
• FT-IR, FT-Raman spectra, and DFT computations of the vibrational spectra and molecular geometry of chlorzoxazone.

  2014cites this paper
• Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Chlorzoxazone and Paracetamol in Tablet Dosage Form

  2014cites this paper
• Paracetamol metabolism in postoperative patients

  2012cites this paper
• Spectrofluorimetric Assessment of Chlorzoxazone and Ibuprofen in Pharmaceutical Formulations by using Eu-Tetracycline HCl Optical Sensor Doped in Sol–Gel Matrix

  2011cites this paper
• Determination of Chlorzoxazone in Rat Plasma by LC-ESI-MS/MS and Its Application to a Pharmacokinetic Study

  2010influential citation
• In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene.

  2010cites this paper
• Year : 2009 In vivo role of cytochrome P 450 2 E 1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans

  2009influential citation
• In vivo Role of Cytochrome P450 2E1 and Glutathione-S-Transferase Activity for Acrylamide Toxicokinetics in Humans

  2009influential citation
• The mechanism of the rat liver cytochrome P4502E1 inhibition by the synthetic prostanoids of A-type.

  2009cites this paper
• Mechanism-Based Inactivation of Lung-Selective Cytochrome P450 CYP2F Enzymes

  2008cites this paper
• Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women.

  2008cites this paper
• Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.

  2008cites this paper
• A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.

  2007cites this paper
• Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.

  2007cites this paper
• Mechanism-Based Inactivation of Lung-Selective Cytochrome P 450 CYP 2 F Enzymes

  2007cites this paper
• Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells

  2007cites this paper
• Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis

  2007cites this paper
• Hepatoprotective action of prostaglandin A2 analogs under CCl4‐induced liver injury in vitro

  2007cites this paper
• Differences in sensitivity of cultured rat brain neuronal and glial cytochrome P450 2E1 to ethanol.

  2006cites this paper
• Chlorzoxazone metabolism is increased in fasted Sprague‐Dawley rats

  2006influential citation
• Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients.

  2006cites this paper
• Cytochrome P450 1A isoenzymes in brain cells: Expression and inducibility in cultured rat brain neuronal and glial cells.

  2006cites this paper
• Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial

  2006cites this paper
• Occupational Toluene Exposure Induces Cytochrome P450 2E1 mRNA Expression in Peripheral Lymphocytes

  2005cites this paper
• Toxicokinetics and metabolism.

  2005cites this paper
• Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.

  2005cites this paper
• Presence of cytochrome P450 enzymes in human CD34+ haematopoietic progenitor cells.

  2004cites this paper
• Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions

  2004influential citation
• “Cocktail” Approaches and Strategies in Drug Development: Valuable Tool or Flawed Science?

  2004cites this paper
• Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung

  2004cites this paper
• Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism

  2003influential citation
• Study of the fragmentation mechanism of protonated 6-hydroxychlorzoxazone: application in simultaneous analysis of CYP2E1 activity with major human cytochrome P450s.

  2003cites this paper
• CYP2E1 regulation by benzene and other small organic chemicals in rat liver and peripheral lymphocytes.

  2003cites this paper
• Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene

  2002cites this paper
• Potentiation of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)-induced liver toxicity by ethanol in guinea-pigs

  2002cites this paper
• Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population

  2002cites this paper
• Validated HPLC method for determination of chlorzoxazone in human serum and its application in a clinical pharmacokinetic study.

  2002cites this paper
• The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone

  2001cites this paper
• Study of cytochrome P4502E1 mRNA level of mononuclear cells in patients with alcoholic liver disease.

  2001cites this paper
• Changes in microsomal activity in alcoholism and obesity.

  2000cites this paper
• Cytochrome P-450 2E1 activity and oxidative stress in alcoholic patients.

  2000cites this paper
• CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals

  2000cites this paper
• CYP2E1 expression in human lymphocytes from various ethnic populations.

  1999cites this paper
• Pharmacology of CFTR chloride channel activity.

  1999cites this paper
• CYP2E1-dependent benzene toxicity: the role of extrahepatic benzene metabolism

  1999cites this paper
• Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid chromatographic method.

  1998cites this paper
• Reversed-phase HPLC method for the estimation of acetaminophen, ibuprofen and chlorzoxazone in formulations.

  1998cites this paper
• Determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma by gas chromatography--mass spectrometry.

  1998cites this paper
• Simultaneous determination of chlorzoxazone, indicator of CYP2E1, and its metabolite in human serum using a new reversed-phase chromatographic column of 2-μm porous microspherical silica-gel

  1998cites this paper
• Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation

  1998cites this paper
• Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress

  1998cites this paper
• Use of Chlorzoxazone as an In Vivo Probe of Cytochrome P450 2E1: Choice of Dose and Phenotypic Trait Measure

  1998cites this paper
• Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics.

  1998cites this paper
• Simultaneous determination of chlorzoxazone, indicator of CYP2E1, and its metabolite in human serum using a new reversed-phase chromatographic column of 2-microm porous microspherical silica-gel.

  1998cites this paper
• Validation of the five‐drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug‐metabolizing enzymes

  1997cites this paper
• Direct injection analysis of chlorzoxazone and its major metabolite 6-hydroxychlorzoxazone in human serum using a semipermeable surface (SPS) HPLC column.

  1997cites this paper
• Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity.

  1997cites this paper
• Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats.

  1997cites this paper
• Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans

  1997cites this paper
• Chlorzoxazone: an in vitro and in vivo substrate probe for liver CYP2E1.

  1996cites this paper
• Immunological detection of CYP2E1 in fresh rat lymphocytes and its pretranslational induction by fasting.

  1996cites this paper
• Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.

  1996cites this paper
• Determination of cytochrome P450 2E1 activity in microsomes by thin-layer chromatography using [2-14C]chlorzoxazone.

  1996cites this paper
• The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A.

  1996cites this paper
• Risk assessment: toxicity from chemical exposure resulting from enhanced expression of CYP2E1.

  1995cites this paper
• Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans.

  1995cites this paper
• Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase.

  1995cites this paper